Tirzepatide/Cagrilintide Blend
Also known as: Tirz/Cagri
Overview
A compounded blend sold by gray-market sellers. No regulator has evaluated this pairing as a fixed combination and no trial supports it.
Tirzepatide/Cagrilintide Blend is classified as a compounded incretin/amylin blend. Its current development status is: not studied as a fixed combination. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.
The Peptide Institute tracks Tirzepatide/Cagrilintide Blend because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Tirzepatide/Cagrilintide Blend
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 2
- Samples
- 2
- Updated
- Jul 4, 2026
- 1 BioRegen Research Excellent Institute
Top Rated Tirzepatide/Cagrilintide Blend94.6% average purity across 1 sample
Purity & Testing 99 Transparency 82 Samples 1 87 View company - 2 NextGen Peptides Excellent
97.6% average purity across 1 sample
Purity & Testing 91 Transparency 80 Samples 1 85 View company
Research & Studies
Studies library-
Immunogenicity and stability profile of Tirzepatide/Cagrilintide Blend
Characterises Tirzepatide/Cagrilintide Blend activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.
Independent Testing
Testing databaseLaboratory verification of Tirzepatide/Cagrilintide Blend products across the companies we index.
Community Discussions
ForumFree download
Get the free Peptide Playbook, plus new breakthroughs as they happen.
What peptides are, why people are using them, and what results people are talking about, in plain English. Sign up and we email you the Playbook right away.
- The Peptide Playbook, free in your inbox
- Occasional updates on new developments
- No spam, unsubscribe anytime